批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
| 审批日期 | 提交号 | 审批结论 | 提交分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 1992/12/16 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
PRIORITY
;Orphan
|
|
|
>>>补充申请<<<
| 审批日期 | 提交号 | 审批结论 | 补充类别或审批类型 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2018/04/17 |
SUPPL-15(补充) |
Approval |
Labeling-Package Insert |
STANDARD
;Orphan
|
|
|
| 2015/05/29 |
SUPPL-13(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2002/04/15 |
SUPPL-8(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2000/05/16 |
SUPPL-7(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 1999/12/15 |
SUPPL-6(补充) |
Approval |
Efficacy-New Indication |
STANDARD
|
|
|
| 1998/12/15 |
SUPPL-5(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 1997/12/01 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC)-Control |
PRIORITY
|
|
|
| 1997/01/27 |
SUPPL-3(补充) |
Approval |
Manufacturing (CMC)-Control |
PRIORITY
|
|
|
| 1995/08/10 |
SUPPL-2(补充) |
Approval |
Manufacturing (CMC)-Packaging |
PRIORITY
|
|
|
| 1995/08/07 |
SUPPL-1(补充) |
Approval |
Labeling |
STANDARD
;Orphan
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
>>>活性成分:LEVOCARNITINE; 剂型/给药途径:INJECTABLE;INJECTION; 规格:200MG/ML; 治疗等效代码:AP<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 020182 |
001 |
NDA |
CARNITOR |
LEVOCARNITINE |
INJECTABLE;INJECTION |
200MG/ML |
Prescription |
Yes |
Yes |
AP |
1992/12/16
|
LEADIANT BIOSCI INC |
| 075567 |
001 |
ANDA |
LEVOCARNITINE |
LEVOCARNITINE |
INJECTABLE;INJECTION |
200MG/ML |
Prescription |
No |
No |
AP |
2001/03/29
|
HIKMA |
| 075861 |
001 |
ANDA |
LEVOCARNITINE |
LEVOCARNITINE |
INJECTABLE;INJECTION |
200MG/ML |
Prescription |
No |
No |
AP |
2001/06/22
|
AM REGENT |
| 217430 |
001 |
ANDA |
LEVOCARNITINE |
LEVOCARNITINE |
INJECTABLE;INJECTION |
200MG/ML |
Prescription |
No |
No |
AP |
2025/06/30
|
DEVA HOLDING AS |